PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine

Go back to PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine
(NASDAQ: PDSB) Delayed: 1.16 -0.08 (6.45%)
Previous Close $1.24    52 Week High $ 
Open $1.16    52 Week Low $ 
Day High $1.22    P/E N/A 
Day Low $1.12    EPS $ 
Volume 5,120,263